Ten pharmaceutical companies, seven disease-related foundations, the drug industry's main trade group and two huge federal agencies have joined together in an unusual collaboration to share information and speed up creation and approval of new drugs needed by patients.
The Accelerating Medicines Partnership, announced Tuesday by the National Institutes of Health, includes these participants:
DRUGMAKERS: AbbVie Inc., Biogen Idec Inc., Bristol-Myers Squibb Co., GlaxoSmithKline PLC, Johnson & Johnson, Eli Lilly and Co., Merck & Co., Pfizer Inc., Sanofi SA and Takeda Pharmaceutical Co.
NONPROFIT FOUNDATIONS: Alzheimer's Association, American Diabetes Association, Foundation for the NIH, Geoffrey Beene Foundation (supports early medical research), Lupus Foundation of America, Rheumatology Research Foundation and USAgainstAlzheimer's
INDUSTRY TRADE GROUP: Pharmaceutical Research and Manufacturers of America
GOVERNMENT AGENCIES: U.S. Food and Drug Administration, National Institutes of Health
Source: National Institutes of Health